Beaumont Health

Beaumont researchers develop COVID-19 test that can detect virus in saliva, blood or urine in 45 minutes

The test can be used at the point of risk – such as nursing homes, cruise ships, naval ships, within the school and prison systems, and by large employers, like Amazon or a meatpacking plant.
7-Jul-2020 11:40 AM EDT, by Beaumont Health contact patient services

Newswise — A team led by Beaumont Health researchers, Laura Lamb, Ph.D. and Michael Chancellor, M.D at the Aikens Research Center at Beaumont Research Institute has identified the technology to develop a detection test for COVID-19 via urine, blood, saliva or a mouth-swab sample in just 30-45 minutes. 

Results were compared to existing technology and found to be highly accurate; the test is also relatively inexpensive to develop and operate.

"We need more testing options if we’re going to stage a successful public health response to COVID-19," Dr. Lamb explained. "This is a rapid test that does not require expensive machinery to run and the materials for it are relatively inexpensive. The more options we have for testing, the better."

Dr. Lamb went on to say the test “could be used for screening at the point of risk – such as nursing homes, long-term care facilities, cruise ships, naval ships, within the school and prison systems, and by large employers, for example, at an Amazon warehouse or meatpacking plant. “We are optimistic that with the right resources and partnerships it could be ready for widespread use by the end of the year."

Securing corporate sponsorship to fund development is the next phase of the journey, Dr. Chancellor said. 

Results from the most accurate tests currently available take 24 hours or more to process; similarly, those tests are expensive for some hospitals and clinics.

Dr. Lamb and Dr. Chancellor came up with the technology for a rapid, Zika virus detection test about three years ago. While the need for that technology faded, Lamb and team were able to swiftly adapt the technology for COVID-19.

“This just shows you how working in one area can jumpstart research in another,” Dr. Chancellor said.

The detection test, Lamb explained, builds on recommendations from Anthony Fauci, M.D., immunologist and director of the National Institute of Allergy and Infectious Diseases since 1984, that rapid testing and tracing are the keys to containing the coronavirus.

This important study by Dr. Lamb and Dr. Chancellor recently appeared in the peer-reviewed, leading medical journal PLOS ONE.

More than 10,000 scientists from around the world have already downloaded the Beaumont research team article. Additionally, Dr. Lamb and Dr. Chancellor are sharing their work and collaborating with researchers from Prague to Africa to South America via video conference.

“We are especially grateful to Beaumont reference labs for providing us with clinical samples to fuel our research,” Dr. Chancellor said.



Beaumont Health is Michigan’s largest health care system and is most preferred for health care in Southeast Michigan, according to NRC Health survey data. The not-for-profit organization was created to provide patients with greater access to compassionate, extraordinary care, every day. Beaumont Health has a total net revenue of $4.7 billion and consists of eight hospitals with 3,429 beds, 145 outpatient sites, nearly 5,000 physicians, 38,000 employees and 3,500 volunteers. In 2018, Beaumont Health had about 178,000 inpatient discharges, 18,000 births and 573,000 emergency visits.

Filters close

Showing results

110 of 2873
access_time Embargo lifts in 2 days
Embargo will expire: 12-Aug-2020 6:00 PM EDT Released to reporters: 11-Aug-2020 11:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Aug-2020 6:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 11-Aug-2020 6:50 PM EDT
Untapped potential for TikTok to convey COVID-19 guidance
De Gruyter

Research published in DeGruyter's International Journal of Adolescent Medicine and Health suggests TikTok is rich with untapped educational potential.

Released: 11-Aug-2020 5:40 PM EDT
Experimental COVID-19 vaccine prevents severe disease in mice
Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis have created a COVID-19 vaccine candidate from a replicating virus. This experimental vaccine has proven effective at preventing pneumonia in mice.

Released: 11-Aug-2020 4:15 PM EDT
Medical Organizations Team Up to Help Parents and Caregivers Navigate Return to Sports and Recreation during COVID-19 Pandemic
American Medical Society for Sports Medicine (AMSSM)

The American Academy of Pediatrics (AAP), American Medical Society For Sports Medicine (AMSSM) and National Athletic Trainers’ Association (NATA) have joined forces to address growing concerns and confusion amid youth sports and recreation participation during the coronavirus pandemic.

Released: 11-Aug-2020 4:10 PM EDT
DHS to Hold Virtual Industry Day Seeking Innovative Solutions for Coronavirus Response
Homeland Security's Science And Technology Directorate

DHS S&T is seeking groundbreaking solutions to address current and future operational needs. S&T issued the Emerging Needs: Covid-19 Response & Future Mitigation topic call through its Silicon Valley Innovation Program (SVIP).

Newswise:Video Embedded bouncing-sticking-exploding-viruses-understanding-the-surface-chemistry-of-sars-cov-2
Released: 11-Aug-2020 3:45 PM EDT
Bouncing, Sticking, Exploding Viruses: Understanding the Surface Chemistry of SARS-CoV-2
Michigan Technological University

Better understanding of the surface chemistry of the SARS-CoV-2 virus is needed to reduce transmission and accelerate vaccine design.

Released: 11-Aug-2020 3:05 PM EDT
High Blood Sugar May Worsen COVID-19 Outcomes
Michigan Medicine - University of Michigan

Preliminary observations of COVID-19 patients with diabetes inspired an algorithm for glucose monitoring that’s suspected to help combat the virus’ serious complications.

Showing results

110 of 2873